The Latin America, Middle East and Africa Chronic Disease Management Market would witness market growth of 14.2% CAGR during the forecast period (2022-2028).
In order to obtain services, health plans typically enter into contracts with vendors, also referred to as disease management organizations. But, some people decide to run the application themselves. Improvements in self-care behaviours and a decrease in the usage of different health care services, such as hospital admissions and ER visits, have been achieved by several disease management programmes. Due to this, costs for certain groups with chronic illnesses have gone down.
Because they are committed to providing complete, coordinated care, managed care organizations are in a good position to practise disease management. They put a strong emphasis on enhancing the health of whole patient populations, effectively utilize the resources at hand, and are held responsible for the calibre of their medical services by patients, customers, and regulators. Education for patients and healthcare professionals, ambulatory care, home health care, acute care, and nursing home services are all integrated by managed care organizations. Better health results are produced as a result of higher patient care continuity.
The United Arab Emirates has transformed into a prosperous, modern nation with a Western way of life from a developing nation with a sizable nomadic population. Certainly, this economic development has given UAE inhabitants social benefits and possibilities, including a high and rising life expectancy. But, a serious issue with chronic diseases, notably cardiovascular risk associated with obesity, has been exacerbated by fast industrialization and urbanization. As a result, the Health Authority of Abu Dhabi has greatly improved its data systems to more accurately determine the starting point and gauge the results of focused interventions.
The Brazil market dominated the LAMEA Chronic Disease Management Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $177.7 million by 2028.The Argentina market is experiencing a CAGR of 14.8% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 13.9% during (2022 - 2028).
Based on Type, the market is segmented into Solutions and Services. Based on End User, the market is segmented into Healthcare Providers, Healthcare Payers and Others. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular diseases, Asthma, Chronic obstructive pulmonary disorders, Cancer and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Chronic Disease Management Market is Predict to reach $9.9 Billion by 2028, at a CAGR of 11.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Infosys Limited, ExlService Holdings, Inc., Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc., Koninklijke Philips N.V., Cognizant Technology Solutions Corporation, Casenet, LLC, Cedar Gate Technologies, Clinical Excellence, Inc., and Altruista Health, Inc.
By Type
By End User
By Disease Type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 